Literature DB >> 15464025

The elusive alpha(1D)-adrenoceptor: molecular and cellular characteristics and integrative roles.

J Adolfo García-Sáinz1, Rafael Villalobos-Molina.   

Abstract

alpha(1)-Adrenoceptors seem to play key roles in cardiovascular, genitourinary, and central nervous system functions. This review will be focused on alpha(1D)-adrenoceptors. These receptors have intrinsic activity, and many of the more commonly used antagonists are in reality inverse agonists. alpha(1D)-Adrenoceptors are phosphorylated in the basal state, and the natural agonists, adrenaline and noradrenaline, increase their phosphorylation; similar effects are induced by direct activation of protein kinase C and through activation of nonadrenergic receptors. Interestingly, a large proportion of alpha(1D)-adrenoceptors are located in intracellular vesicles. Such intracellular location can be changed to surface expression through the use of inverse agonists and coexpression of alpha(1B)-adrenoceptors, which seem to act as pharmacological chaperons for proper plasma membrane insertion. The alpha(1D)-adrenoceptor amino terminus seems to contain a signal that keeps the receptor intracellularly, but interaction with other proteins may also contribute. The precise relationship between the intrinsic activity, phosphorylation, and intracellular location is currently unknown. alpha(1D)-Adrenoceptor activation induces contraction in a variety of vessels, and a role in the control of blood pressure has been suggested. Studies using young prehypertensive and adult spontaneously hypertensive rats as well as knockout mice suggest that vascular alpha(1D)-adrenoceptors are involved in the genesis/maintenance of hypertension.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15464025     DOI: 10.1016/j.ejphar.2004.07.016

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

Review 1.  Central nervous system biogenic amine targets for control of appetite and energy expenditure.

Authors:  David L Nelson; Donald R Gehlert
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

2.  Signaling properties of human alpha(1D)-adrenoceptors lacking the carboxyl terminus: intrinsic activity, agonist-mediated activation, and desensitization.

Authors:  C Ekaterina Rodríguez-Pérez; M Teresa Romero-Avila; Guadalupe Reyes-Cruz; J Adolfo García-Sáinz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-05-21       Impact factor: 3.000

3.  Addition of a signal peptide sequence to the alpha1D-adrenoceptor gene increases the density of receptors, as determined by [3H]-prazosin binding in the membranes.

Authors:  Ramona Petrovska; Ivo Kapa; Janis Klovins; Helgi B Schiöth; Staffan Uhlén
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

4.  Vascular alpha-1D-adrenoceptors are overexpressed in aorta of the aryl hydrocarbon receptor null mouse: role of increased angiotensin II.

Authors:  R Villalobos-Molina; F G Vázquez-Cuevas; J J López-Guerrero; M C Figueroa-García; I A Gallardo-Ortiz; M Ibarra; M Rodríguez-Sosa; F J Gonzalez; G Elizondo
Journal:  Auton Autacoid Pharmacol       Date:  2008 Apr-Jul

5.  Carboxyl terminus-truncated α1D-adrenoceptors inhibit the ERK pathway.

Authors:  Marco A Alfonzo-Méndez; Jean A Castillo-Badillo; M Teresa Romero-Ávila; Richard Rivera; Jerold Chun; J Adolfo García-Sáinz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-05-05       Impact factor: 3.000

6.  Influence of combined hypertension and renal failure on functional alpha(1)-adrenoceptor subtypes in the rat kidney.

Authors:  M A Hye Khan; M A Sattar; N A Abdullah; E J Johns
Journal:  Br J Pharmacol       Date:  2008-02-11       Impact factor: 8.739

Review 7.  Long-term consequences of drugs on the paediatric cardiovascular system.

Authors:  Elizabeth Hausner; Monica L Fiszman; Joseph Hanig; Patricia Harlow; Gwen Zornberg; Solomon Sobel
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

8.  Endogenous N-terminal Domain Cleavage Modulates α1D-Adrenergic Receptor Pharmacodynamics.

Authors:  Timothy S Kountz; Kyung-Soon Lee; Stacey Aggarwal-Howarth; Elizabeth Curran; Ji-Min Park; Dorathy-Ann Harris; Aaron Stewart; Joseph Hendrickson; Nathan D Camp; Alejandro Wolf-Yadlin; Edith H Wang; John D Scott; Chris Hague
Journal:  J Biol Chem       Date:  2016-07-05       Impact factor: 5.157

9.  α1D-Adrenoceptors are responsible for the high sensitivity and the slow time-course of noradrenaline-mediated contraction in conductance arteries.

Authors:  Nicla Flacco; Jaime Parés; Eva Serna; Vanessa Segura; Diana Vicente; Miguel Pérez-Aso; María Antonia Noguera; María Dolores Ivorra; John C McGrath; Pilar D'Ocon
Journal:  Pharmacol Res Perspect       Date:  2013-08-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.